v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 17,647 $ 19,655
Short-term investments 85,391 94,942
Accounts receivable, net 26,825 25,622
Insurance recovery receivable related to legal loss (Note 8) 8,084 8,039
Prepaid expenses and other current assets 4,574 4,736
Total current assets 142,521 152,994
Property and equipment, net 7,391 7,583
Operating lease right-of-use assets 5,535 6,121
Other intangible assets, net 161 206
Goodwill 5,898 5,898
Other assets 866 837
Total assets 162,372 173,639
Current liabilities:    
Accounts payable 2,702 3,888
Accrued expenses 7,797 6,533
Accrued legal loss (Note 8) 11,500 11,500
Accrued salary and benefits 4,935 10,457
Deferred revenue 4,338 5,382
Operating leases 2,681 2,624
Finance leases 44 44
Total current liabilities 33,997 40,428
Operating leases, non-current 3,535 4,231
Finance leases, non-current 61 72
Other liabilities 832 801
Total liabilities 38,425 45,532
Commitments and contingencies (Note 8)
Stockholders’ equity    
Preferred stock $0.005 par value, 100,000 shares authorized and no shares issued and outstanding as of March 31, 2026 and December 31, 2025 0 0
Common stock $0.005 par value, 1,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 64,134 and 63,264 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively 321 317
Additional paid-in capital 475,067 469,560
Accumulated other comprehensive (loss) income (21) 32
Accumulated deficit (351,420) (341,802)
Total stockholders’ equity 123,947 128,107
Total liabilities and stockholders’ equity $ 162,372 $ 173,639